A Seven-Year Prospective Study on Spondylodiscitis: Epidemiological and Microbiological Features
Background: The aim of this paper was to enlarge the available knowledge on clinical and etiological aspects of patients affected by spondylodiscitis. Patients and Methods: All patients with spondylodiscitis admitted between January 2001 and December 2007 at the 1,300-bed University Hospital "Policlinico Umberto I" of Rome, Italy, were followed. Demographic characteristics, underlying diseases, invasive procedures, imaging studies, isolated microorganisms, treatment, complications, and outcome were recorded. Results: Eighty-one patients of mean age 57.7 ± 14.7 years with lumbosacral (72.8%), thoracic (14.8%), and cervical tract (12.3%) site of infection were included, of which 38 developed communityacquired (CA) spondylodiscitis and 43 developed hospital-acquired (HA) spondylodiscitis. Underlying disease was present in 49.4% of patients. HA spondylodiscitis was diagnosed earlier (46.8 ± 49.7 days) than CA spondylodiscitis (65.0 ± 55.4 days) (P < 0.05). The most frequently isolated microorganisms were Staphylococcus aureus (28 strains, 43.1%), coagulase-negative staphylococci (CNS) (eight strains, 12.3%), Pseudomonas aeruginosa (eight strains, 12.3%), and three methicillin-resistant S. aureus (MRSA) strains were isolated in CA spondylodiscitis. Fungi and yeasts, isolated in six patients, represented 9.2% of all strains but 17.6% when considering only HA spondylodiscitis. Over 85% of patients were managed by conservative treatment alone, and the treatment time depended on clinical and laboratory evidence. Poor outcome was recorded in 12 (14.8%) patients, and was associated with neurological deficit symptoms (relative risk [RR] 2.87; 95% confidence interval [CI] 1.02–8.07; P < 0.05) and the time between diagnosis and the onset of symptoms ≥ 60 days (RR 2.65; 95% CI 0.92–7.59; P < 0.05). Conclusions: Infectious spondylodiscitis affects most frequently the elderly population, who are more exposed to healthcare contacts. Consequently, the infection etiology includes a growing proportion of multi-resistant bacteria and fungi..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2010 |
---|---|
Erschienen: |
2010 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
Infection - 38(2010), 2 vom: 27. Feb., Seite 102-107 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
D’Agostino, C. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Discitis |
doi: |
10.1007/s15010-009-9340-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR032549385 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR032549385 | ||
003 | DE-627 | ||
005 | 20230519194525.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2010 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s15010-009-9340-8 |2 doi | |
035 | |a (DE-627)SPR032549385 | ||
035 | |a (SPR)s15010-009-9340-8-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.75 |2 bkl | ||
100 | 1 | |a D’Agostino, C. |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Seven-Year Prospective Study on Spondylodiscitis: Epidemiological and Microbiological Features |
264 | 1 | |c 2010 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: The aim of this paper was to enlarge the available knowledge on clinical and etiological aspects of patients affected by spondylodiscitis. Patients and Methods: All patients with spondylodiscitis admitted between January 2001 and December 2007 at the 1,300-bed University Hospital "Policlinico Umberto I" of Rome, Italy, were followed. Demographic characteristics, underlying diseases, invasive procedures, imaging studies, isolated microorganisms, treatment, complications, and outcome were recorded. Results: Eighty-one patients of mean age 57.7 ± 14.7 years with lumbosacral (72.8%), thoracic (14.8%), and cervical tract (12.3%) site of infection were included, of which 38 developed communityacquired (CA) spondylodiscitis and 43 developed hospital-acquired (HA) spondylodiscitis. Underlying disease was present in 49.4% of patients. HA spondylodiscitis was diagnosed earlier (46.8 ± 49.7 days) than CA spondylodiscitis (65.0 ± 55.4 days) (P < 0.05). The most frequently isolated microorganisms were Staphylococcus aureus (28 strains, 43.1%), coagulase-negative staphylococci (CNS) (eight strains, 12.3%), Pseudomonas aeruginosa (eight strains, 12.3%), and three methicillin-resistant S. aureus (MRSA) strains were isolated in CA spondylodiscitis. Fungi and yeasts, isolated in six patients, represented 9.2% of all strains but 17.6% when considering only HA spondylodiscitis. Over 85% of patients were managed by conservative treatment alone, and the treatment time depended on clinical and laboratory evidence. Poor outcome was recorded in 12 (14.8%) patients, and was associated with neurological deficit symptoms (relative risk [RR] 2.87; 95% confidence interval [CI] 1.02–8.07; P < 0.05) and the time between diagnosis and the onset of symptoms ≥ 60 days (RR 2.65; 95% CI 0.92–7.59; P < 0.05). Conclusions: Infectious spondylodiscitis affects most frequently the elderly population, who are more exposed to healthcare contacts. Consequently, the infection etiology includes a growing proportion of multi-resistant bacteria and fungi. | ||
650 | 4 | |a Infective Endocarditis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Epidural Abscess |7 (dpeaa)DE-He213 | |
650 | 4 | |a Microbiological Feature |7 (dpeaa)DE-He213 | |
650 | 4 | |a Vertebral Osteomyelitis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Discitis |7 (dpeaa)DE-He213 | |
700 | 1 | |a Scorzolini, L. |e verfasserin |4 aut | |
700 | 1 | |a Massetti, A. P. |e verfasserin |4 aut | |
700 | 1 | |a Carnevalini, M. |e verfasserin |4 aut | |
700 | 1 | |a d’Ettorre, G. |e verfasserin |4 aut | |
700 | 1 | |a Venditti, M. |e verfasserin |4 aut | |
700 | 1 | |a Vullo, V. |e verfasserin |4 aut | |
700 | 1 | |a Orsi, G. B. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Infection |d München : Urban & Vogel, 1973 |g 38(2010), 2 vom: 27. Feb., Seite 102-107 |w (DE-627)SPR032536909 |w (DE-600)2006315-5 |x 1439-0973 |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2010 |g number:2 |g day:27 |g month:02 |g pages:102-107 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s15010-009-9340-8 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.75 |q ASE |
951 | |a AR | ||
952 | |d 38 |j 2010 |e 2 |b 27 |c 02 |h 102-107 |